Inactive Instrument
Abpro Corporation Stock Nasdaq
Stocks
US0008501076
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.3M 2.01M 1.89M 1.72M 3.22M 221M 3.23M 22.68M 8.75M 112M 8.64M 8.45M 361M | P/E 2024 |
-2.41x | P/E 2025 | -3.27x |
|---|---|---|---|---|---|
| Enterprise Value | 2.38M 2.07M 1.96M 1.78M 3.33M 228M 3.35M 23.47M 9.06M 116M 8.94M 8.74M 374M | EV / Sales 2024 |
497x | EV / Sales 2025 | - |
| Free-Float |
83.91% | Yield 2024 * |
-
| Yield 2025 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.36M | |
| +0.11% | +2.71% | +0.33% | +28.59% | 46.18B | |
| -1.12% | +1.78% | +40.07% | +27.26% | 44.35B | |
| -3.04% | -6.29% | +322.27% | +517.36% | 42.21B | |
| -0.74% | +1.25% | +2.32% | +67.94% | 40.19B | |
| -0.50% | +0.67% | +11.79% | +40.51% | 29.83B | |
| -0.46% | +4.22% | +21.99% | +124.21% | 17.17B | |
| -0.97% | -10.17% | - | - | 15.7B | |
| -0.57% | +8.12% | +22.15% | +38.93% | 15.32B | |
| -3.28% | -3.07% | -8.54% | -37.61% | 13.09B | |
| Average | -1.06% | +0.70% | +51.55% | +100.90% | 29.34B | |
| Weighted average by Cap. | -1.11% | +0.85% | +66.22% | +122.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183K 160K 151K 137K 256K 17.56M 257K 1.8M 696K 8.93M 687K 672K 28.73M | - |
| Net income | -7.23M -6.31M -5.95M -5.41M -10.13M -694M -10.17M -71.33M -27.52M -353M -27.17M -26.56M -1.14B | -2.89M -2.52M -2.38M -2.16M -4.05M -278M -4.07M -28.52M -11.01M -141M -10.86M -10.62M -454M |
| Net Debt | 478K 417K 394K 357K 670K 45.87M 672K 4.71M 1.82M 23.32M 1.8M 1.76M 75.03M | 80K 69.76K 65.87K 59.81K 112K 7.68M 113K 789K 304K 3.9M 301K 294K 12.56M |
Employees
-
